Octreotide LAR for severe obscure-overt gastrointestinal haemorrhage in high-risk patients on anticoagulation therapy.
Molina-Infante
J
J
Perez-Gallardo
B
B
Gonzalez-Garcia
G
G
Fernandez-Bermejo
M
M
Mateos-Rodriguez
J M
JM
Robledo-Andres
P
P
D000368:Aged; D000925:Anticoagulants / Q000009:adverse effects*; D003692:Delayed-Action Preparations; D005765:Gastrointestinal Agents / Q000627:therapeutic use*; D006471:Gastrointestinal Hemorrhage / Q000188:drug therapy*; D006801:Humans; D008297:Male; D015282:Octreotide / Q000627:therapeutic use*; D012008:Recurrence
D000925:Anticoagulants; D003692:Delayed-Action Preparations; D005765:Gastrointestinal Agents; D015282:Octreotide